These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15908963)

  • 21. Crystal structure of human lectin-like, oxidized low-density lipoprotein receptor 1 ligand binding domain and its ligand recognition mode to OxLDL.
    Ohki I; Ishigaki T; Oyama T; Matsunaga S; Xie Q; Ohnishi-Kameyama M; Murata T; Tsuchiya D; Machida S; Morikawa K; Tate S
    Structure; 2005 Jun; 13(6):905-17. PubMed ID: 15939022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the S810L point mutation of the mineralocorticoid receptor in patients with pregnancy-induced hypertension.
    Schmider-Ross A; Wirsing M; Büscher U; Neitzel H; Krause M; Henrich W; Reles A; Dudenhausen JW
    Hypertens Pregnancy; 2004; 23(1):113-9. PubMed ID: 15117605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47.
    Nakaishi A; Hirose M; Yoshimura M; Oneyama C; Saito K; Kuki N; Matsuda M; Honma N; Ohnishi H; Matozaki T; Okada M; Nakagawa A
    J Mol Biol; 2008 Jan; 375(3):650-60. PubMed ID: 18045614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ligand-induced conformational changes in the mineralocorticoid receptor analyzed by protease mapping.
    Trapp T; Holsboer F
    Biochem Biophys Res Commun; 1995 Oct; 215(1):286-91. PubMed ID: 7575603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The evolution of mineralocorticoid receptors.
    Hu X; Funder JW
    Mol Endocrinol; 2006 Jul; 20(7):1471-8. PubMed ID: 16195247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular evolution of the switch for progesterone and spironolactone from mineralocorticoid receptor agonist to antagonist.
    Fuller PJ; Yao YZ; Jin R; He S; Martín-Fernández B; Young MJ; Smith BJ
    Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18578-18583. PubMed ID: 31439819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystallization of protein-ligand complexes.
    Hassell AM; An G; Bledsoe RK; Bynum JM; Carter HL; Deng SJ; Gampe RT; Grisard TE; Madauss KP; Nolte RT; Rocque WJ; Wang L; Weaver KL; Williams SP; Wisely GB; Xu R; Shewchuk LM
    Acta Crystallogr D Biol Crystallogr; 2007 Jan; 63(Pt 1):72-9. PubMed ID: 17164529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal structures of thymidylate synthase mutant R166Q: structural basis for the nearly complete loss of catalytic activity.
    Sotelo-Mundo RR; Changchien L; Maley F; Montfort WR
    J Biochem Mol Toxicol; 2006; 20(2):88-92. PubMed ID: 16615077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-function relationships in the mineralocorticoid receptor.
    Pippal JB; Fuller PJ
    J Mol Endocrinol; 2008 Dec; 41(6):405-13. PubMed ID: 18805937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereochemical requirements for the mineralocorticoid receptor antagonist activity of dihydropyridines.
    Arhancet GB; Woodard SS; Dietz JD; Garland DJ; Wagner GM; Iyanar K; Collins JT; Blinn JR; Numann RE; Hu X; Huang HC
    J Med Chem; 2010 May; 53(10):4300-4. PubMed ID: 20408553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural origins for selectivity and specificity in an engineered bacterial repressor-inducer pair.
    Klieber MA; Scholz O; Lochner S; Gmeiner P; Hillen W; Muller YA
    FEBS J; 2009 Oct; 276(19):5610-21. PubMed ID: 19712110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligand binding to the human MT2 melatonin receptor: the role of residues in transmembrane domains 3, 6, and 7.
    Mazna P; Berka K; Jelinkova I; Balik A; Svoboda P; Obsilova V; Obsil T; Teisinger J
    Biochem Biophys Res Commun; 2005 Jul; 332(3):726-34. PubMed ID: 15913560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The functional role of cysteines adjacent to the NRY motif of the human MT1 melatonin receptor.
    Kokkola T; Salo OM; Poso A; Laitinen JT
    J Pineal Res; 2005 Aug; 39(1):1-11. PubMed ID: 15978051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism.
    Pujo L; Fagart J; Gary F; Papadimitriou DT; Claës A; Jeunemaître X; Zennaro MC
    Hum Mutat; 2007 Jan; 28(1):33-40. PubMed ID: 16972228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystal structures of human Delta4-3-ketosteroid 5beta-reductase (AKR1D1) reveal the presence of an alternative binding site responsible for substrate inhibition.
    Faucher F; Cantin L; Luu-The V; Labrie F; Breton R
    Biochemistry; 2008 Dec; 47(51):13537-46. PubMed ID: 19075558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tweaking agonist efficacy at N-methyl-D-aspartate receptors by site-directed mutagenesis.
    Hansen KB; Clausen RP; Bjerrum EJ; Bechmann C; Greenwood JR; Christensen C; Kristensen JL; Egebjerg J; Bräuner-Osborne H
    Mol Pharmacol; 2005 Dec; 68(6):1510-23. PubMed ID: 16131614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temperature-dependent variations of ligand-receptor contact points in hAT(1).
    Arsenault J; Renaud MP; Clément M; Fillion D; Guillemette G; Leduc R; Lavigne P; Escher E
    J Pept Sci; 2007 Sep; 13(9):575-80. PubMed ID: 17600857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation of testosterone production in rat Leydig cells by aldosterone is mineralocorticoid receptor mediated.
    Ge RS; Dong Q; Sottas CM; Latif SA; Morris DJ; Hardy MP
    Mol Cell Endocrinol; 2005 Nov; 243(1-2):35-42. PubMed ID: 16188378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.
    Skeldal S; Larsen JV; Pedersen KE; Petersen HH; Egelund R; Christensen A; Jensen JK; Gliemann J; Andreasen PA
    FEBS J; 2006 Nov; 273(22):5143-59. PubMed ID: 17042782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.